Werewolf Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Werewolf Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Werewolf Therapeutics Inc
Rating: 1.15566675
Author: Trendlyne DVM scores

about

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditional...

1.06 -0.01 (-0.93%)

74.64% Fall from 52W High

13,283

XNAS Volume

XNAS 10 Jul, 2025 9:30 AM (EDT)

Not Eligible

Expensive Valuation

16.2 / 100

Technically Bearish

30.1 / 100

1Yr Price target upside is 796%

6 analysts

Werewolf Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Werewolf Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditional...

74.64% Fall from 52W High

SWOT Analysis

Werewolf Therapeutics Inc Live Price Chart